Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds

DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a scheduled presentation at the upcoming ACS Clinical Congress 2026, being held September 26-29, 2026 in Washington, DC.

Entitled “Artificial Intelligence Training & Validation of Multi-Spectral Imaging Device for Evaluation of Burn Wounds,” the presentation will be led by James H. Holmes IV, MD, FACS, FABA, Director of the Burn Center at Atrium Health Wake Forest Baptist Medical Center and Professor of Surgery and Regenerative Medicine at Wake Forest University. The study reflects the contributions of a multidisciplinary group of clinicians and researchers from leading burn centers and academic institutions across the country, including Dr. J. Michael DiMaio, Spectral AI’s Chairman of the Board.